CRISPR-Cas guides the future of genetic engineering
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
The diversity, modularity, and efficacy of CRISPR-Cas systems are driving a biotechnological revolution. RNA-guided Cas enzymes have been adopted as tools to manipulate the genomes of cultured cells, animals, and plants, accelerating the pace of fundamental research and enabling clinical and agricultural breakthroughs. We describe the basic mechanisms that set the CRISPR-Cas toolkit apart from other programmable gene-editing technologies, highlighting the diverse and naturally evolved systems now functionalized as biotechnologies. We discuss the rapidly evolving landscape of CRISPR-Cas applications, from gene editing to transcriptional regulation, imaging, and diagnostics. Continuing functional dissection and an expanding landscape of applications position CRISPR-Cas tools at the cutting edge of nucleic acid manipulation that is rewriting biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR-Cas9 and related enzymes have been used to manipulate the genomes of cultured cells, animals and plants, vastly accelerating the pace of fundamental research and enabling breakthroughs in agriculture and synthetic biology (reviewed in refs. 6-9).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,761
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Chen, J. S., Ma, E., Harrington, L. B., Da Costa, M., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aar6245 · Cited by 4,507
Self-citationProgrammable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
Nucleic acid detection with CRISPR-Cas13a/C2c2
Gootenberg, J. S., Abudayyeh, O. O., Lee, J. W., Essletzbichler, P., Dy, A. J., Joung, J., Verdine, V., Donghia, N., Daringer, N. M., Freije, C. A., et al. (2017) · Science · doi:10.1126/science.aam9321 · Cited by 3,844
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Research works printed but not linked: 3
- 47. Rousseau BA, Hou Z, Gramelspacher MJ, Zhang Y, Mol. Cell (2018), doi:10.1016/j.molcel. 2018.01.025. · doi:10.1016/j.molcel
- 63. Chen JS, Ma E, Harrington LB, Tian X, Doudna JA, bioRxiv, 226993 (2017).
- 71. Charlesworth CT et al., bioRxiv, 243345 (2018).
Cited by
Items 501–600 of 1,000
CRISPRa-mediated FOXP3 gene upregulation in mammalian cells
Forstnerič, V., Oven, I., Ogorevc, J., Lainšček, D., Praznik, A., Lebar, T., Jerala, R., & Horvat, S. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0357-0 · Cited by 27
CRISPR Guide RNA Design Guidelines for Efficient Genome Editing
Schindele, P., Wolter, F., & Puchta, H. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0712-1_19 · Cited by 27
Li, X., Zhao, D., & Hu, X. (2020) · Scientometrics · doi:10.1007/s11192-020-03537-y · Cited by 24
“2016), gene editing has become one of the top scientific and technological hot topics (Robert 2013; Travis 2015; Guterman 2018; Knott and Doudna 2018; Wang et al. 2019).”
BackgroundUmaña, A., Nguyen, T. T. D., Sanders, B. E., Williams, K. J., Wozniak, B., & Slade, D. J. (2022) · Journal of Bacteriology · doi:10.1128/jb.00279-22 · Cited by 24
Chen, D., Liang, Y., Wang, H., Wang, H., Su, F., Zhang, P., Wang, S., Liu, W., & Li, Z. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c05767 · Cited by 25
Genetic architecture of human brain evolution
Fair, T., & Pollen, A. A. (2023) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2023.102710 · Cited by 26
Ashok, K. R., Bhargava, C. N., Asokan, R., Pradeep, C., Pradhan, S. K., Samuel, K. J., Balasubramani, V., Murugan, M., Mannu, J., Geethalakshmi, V., et al. (2023) · 3 Biotech · doi:10.1007/s13205-023-03798-3 · Cited by 27
“The CRISPR/ Cas9 system is much more practical, simple and more powerful than ZFNs and TALENs, therefore, it is becoming a successful genome editing tool (Cong et al. 2013; Doudna and Charpentier 2014; Knott and Doudna 2018).”
BackgroundYee, B. J., Ali, N. A., Mohd‐Naim, N. F., & Ahmed, M. U. (2024) · Chem & Bio Engineering · doi:10.1021/cbe.3c00112 · Cited by 28
Targeted genome editing for cotton improvement: prospects and challenges
Kumar, R., Das, J., Raghavendra, K. P., Kumar, M., Balasubramani, G., & Prasad, Y. G. (2024) · The Nucleus · doi:10.1007/s13237-024-00479-1 · Cited by 25
Generating, modeling and evaluating a large-scale set of CRISPR/Cas9 off-target sites with bulges
Yaish, O., & Orenstein, Y. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae428 · Cited by 26
Yamamoto, S. (2020) · Development Growth & Differentiation · doi:10.1111/dgd.12640 · Cited by 25
“…genome editing technologies such as the CRISPR/Cas9 system are allowing scientists to introduce virtually any mutation into any gene in any species (Knott & Doudna, 2018), forward genetic screens using chemical mutagens such as EMS will still be one of the most powerful ways to reveal specific…”
Harnessing the Potential of Stem Cells for Disease Modeling: Progress and Promises
Argentati, C., Tortorella, I., Bazzucchi, M., Morena, F., & Martino, S. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10010008 · Cited by 25
“Specifically, CRISPR/Cas9 is engineered to edit DNA in stem cell models by designing specific guide RNA (gRNA) complementary to the target sequence (for extensive description see references [102] [103] [104] [105] [106] and Table 3 for computational tools for the design of gRNA).”
BackgroundApplication of CRISPR/Cas9-Mediated Genome Editing in Leishmania
Zhang, W., Lypaczewski, P., & Matlashewski, G. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0294-2_14 · Cited by 24
Development and Application of CRISPR-Cas Based Tools
Hu, Y., & Li, W. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.834646 · Cited by 26
Fieni, C., Ciummo, S. L., Sorrentino, C., Marchetti, S., Vespa, S., Lanuti, P., Lotti, L. V., & Carlo, E. D. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.09.011 · Cited by 24
“CRISPR-Cas9 is the most developed and widely used tool for current genome editing strategies 69 since it is highly speci fi c, ef fi cient, and versatile, 70 and it has already entered clinical trials for the treatment of different human diseases, including cancer.”
RNA Structure: Past, Future, and Gene Therapy Applications
Haseltine, W. A., Hazel, K., & Patarca, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010110 · Cited by 28
Hydrogels Modulating the Microbiome: Therapies for Tissue Regeneration with Infection Control
Jiménez-Gastélum, G., Villegas‐Mercado, C. E., Cota-Quintero, J. L., Arzola-Rodríguez, S. I., Ramos‐Payán, R., & Bermúdez, M. (2025) · Gels · doi:10.3390/gels11080584 · Cited by 25
“Its open and closed states are controlled by how well the gRNA and target DNA bind together [137,138].”
He, Y., Zhang, Y., Xiang, H., Ren, K., Yin, Y., Gao, Y., Yang, Y., Zhang, W., Liu, L.-Z., Han, H., et al. (2025) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2025.117986 · Cited by 23
Ausems, C. R. M., van Engelen, B. G. M., van Bokhoven, H., & Wansink, D. G. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10100-y · Cited by 26
Campa, A. R., Smith, L. M., Hampton, H. G., Sharma, S., Jackson, S. A., Bischler, T., Sharma, C. M., & Fineran, P. C. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab704 · Cited by 23
“The structures and mechanisms of CRISPR–Cas systems, and their biotechnological applications have been studied extensively (9).”
BackgroundMolecular Mechanism of D1135E-Induced Discriminated CRISPR-Cas9 PAM Recognition
Kang, M., Zuo, Z., Yin, Z., & Gu, J. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c01562 · Cited by 23
Manzar, N., Jayaswal, D., Kishan, G., Chauhan, S., Joshi, D., Singh, J. P., Chaudhary, P., Jamali, H., Kushwaha, P., Parveen, H., et al. (2022) · Microorganisms for sustainability · doi:10.1007/978-981-19-5872-4_3 · Cited by 26
Noncoding RNAs in esophageal cancer: A glimpse into implications for therapy resistance
Yang, Z. P., Ma, R., Li, J., & Zhao, L. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106678 · Cited by 25
Maashi, M. S. (2023) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2023.2188955 · Cited by 23
“[33] The crRNA commonly contained two effective domains of an activated area and a guide area.”
Ashok, K. R., Bhargava, C. N., Asokan, R., Pradeep, C., Kennedy, J. S., Manamohan, M., & Rai, A. K. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126557 · Cited by 24
Carpenter, M. A., Law, E. K., Serebrenik, A. A., Brown, W. L., & Harris, R. S. (2018) · Methods · doi:10.1016/j.ymeth.2018.12.006 · Cited by 26
Application of the CRISPR/Cas System for Generation of Pathogen-Resistant Plants
Makarova, S. S., Хромов, А. В., Spechenkova, N. A., Taliansky, M. E., & Kalinina, N. O. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918120131 · Cited by 24
Targeted Oligonucleotides for Treating Neurodegenerative Tandem Repeat Diseases
Zain, R., & Rjh, S. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00712-9 · Cited by 25
SpRY: Engineered CRISPR/Cas9 Harnesses New Genome-Editing Power
Zhang, D., & Zhang, B. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.05.001 · Cited by 23
Recent advances in the microbial production of isopentanol (3-Methyl-1-butanol)
Runguphan, W., Sae-Tang, K., & Tanapongpipat, S. (2021) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-021-03074-7 · Cited by 26
“2012; Knott and Doudna 2018).”
Advantages, risks and legal perspectives of GMOs in 2020s
Uslu, T. (2021) · Plant Biotechnology Reports · doi:10.1007/s11816-021-00714-0 · Cited by 27
Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1
Liu, J., Guo, Z., Yan, X., Yang, Y., & Huang, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.755392 · Cited by 24
Parameshwaran, H. P., Babu, K., Tran, C. N., Guan, K., Allen, A., Kathiresan, V., Qin, P. Z., & Rajan, R. (2021) · FEBS Letters · doi:10.1002/1873-3468.14051 · Cited by 22
Aregger, M., Xing, K., & Gonatopoulos-Pournatzis, T. (2021) · Nature Protocols · doi:10.1038/s41596-021-00595-1 · Cited by 24
Zhao, Z., Shang, P., Sage, F., & Geijsen, N. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac118 · Cited by 25
“Since their discovery, CRISPR / Cas systems have quickly become the editing technology of choice for targeted genome manipulation (9– 12).”
Computationally designed hyperactive Cas9 enzymes
Vos, P. D., Rossetti, G., Mantegna, J. L., Siira, S. J., Gandadireja, A. P., Bruce, M., Raven, S. A., Khersonsky, O., Fleishman, S. J., Filipovska, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30598-9 · Cited by 23
“T he myriad applications of Cas9 have signi fi cantly accelerated biological research 1 – 4 , however, a number of unsolved issues still remain. to the Perhaps the most surprising limitation CRISPR-Cas system is that Cas9 has been found to be particularly inef fi cient in its cleavage activity.”
BackgroundReal-time imaging of RNA polymerase I activity in living human cells
Fu, Y., Liu, Y., Wen, T., Fang, J., Chen, Y., Zhou, Z., Gu, X., Wu, H., Sheng, J., Xu, Z., et al. (2022) · The Journal of Cell Biology · doi:10.1083/jcb.202202110 · Cited by 23
“The development of LiveArt benefits from advances in the CRISPR-Cas technology (Chen et al., 2020; Knott and Doudna, 2018; Suzuki et al., 2016).”
MethodHong, W., Xie, X., Gu, W., Zheng, Z., Zhuo, J., Shao, Z., Huan, L., Zhang, B., Niu, J., Gao, S., et al. (2024) · New Phytologist · doi:10.1111/nph.20123 · Cited by 25
“These tools facilitate precise genome editing across a diverse array of cell types and organisms (Knott & Doudna, 2018), including some marine species.”
Miao, K., Zhang, X., Su, S. M., Zeng, J., Huang, Z., Chan, U. I., Xu, X., & Deng, C. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006496 · Cited by 23
“Unintended binding, modification, and cleavage of nucleic acids, so called the off-target effect, is a major challenge to the CRISPR/Cas9 system (3).”
BackgroundMethodApplications of CRISPR-Cas in Bioengineering, Biotechnology, and Translational Research
Lau, C. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0026 · Cited by 24
From single bacterial cell imaging towards in vivo single-molecule biochemistry studies
Endesfelder, U. (2019) · Essays in Biochemistry · doi:10.1042/ebc20190002 · Cited by 25
A novel therapeutic modality using CRISPR-engineered dendritic cells to treat allergies
Kim, B., Lee, Y. E., Yeon, J. W., Go, G.-Y., Byun, J., Lee, K., Lee, H. K., Hur, J. K., Jang, M., & Kim, T. H. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120798 · Cited by 22
Yang, M., Sun, R., Deng, P., Yang, Y., Wang, W., Liu, J., & Chen, C. (2021) · Chemical Science · doi:10.1039/d1sc02633j · Cited by 26
Takasugi, P., Wang, S., Truong, K. T., Drage, E. P., Kanishka, S. N., Higbee, M. A., Bamidele, N., Ojelabi, O., Sontheimer, E. J., & Gagnon, J. A. (2021) · Genetics · doi:10.1093/genetics/iyab196 · Cited by 26
“CRISPR-Cas systems have several advantages over previous systems, such as zinc-finger nucleases and transcription activator-like effector nucleases, including the ease of design and use, low cost, high efficiency, and customizability (Adli 2018; Knott and Doudna 2018; K. Liu et al. 2019).”
BackgroundSynthetic CRISPR Networks Driven by Transcription Factors via Structure-Switching DNA Translators
Capelli, L., Marzari, S., Spezzani, E., & Bertucci, A. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c06913 · Cited by 21
Wang, D., Gao, F., Hu, F., Zhang, S.-H., Xu, P., & Wu, J. (2020) · BMC Medical Genetics · doi:10.1186/s12881-020-0963-z · Cited by 21
Han, X., Gao, Y., Li, G., Xiong, Y., Zhao, C., Ruan, J., Ma, Y., Li, X., Li, C., Zhao, S., et al. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00496-y · Cited by 21
Targeting G-quadruplex Forming Sequences with Cas9
Balci, H., Globyte, V., & Joo, C. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.0c00687 · Cited by 22
“8,9 However, Cas9 has been the most widely used system due to the simplicity of the CRISPR − Cas9 complex and its high speci fi city.”
A Cas12a-based CRISPR interference system for multigene regulation in mycobacteria
Fleck, N. D., & Grundner, C. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100990 · Cited by 21
“The adaptive bacterial immune systems based on clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins (Cas) have transformed genetic manipulation, and the ease with which they can be programmed has led to their wide use in gene editing in eukaryotes and prokaryotes (1).”
BackgroundCRISPR / LbCas12a ‐mediated targeted mutation of Gracilariopsis lemaneiformis (Rhodophyta)
Zhang, J., Wu, Q., Eléouët, M., Chen, R., Chen, H., Zhang, N., Hu, Y., & Sui, Z. (2022) · Plant Biotechnology Journal · doi:10.1111/pbi.13949 · Cited by 21
“The CRISPR/Cas genome editing system has achieved high popularity in recent years (Knott and Doudna, 2018).”
BackgroundMa, T., Chen, X., & Wang, M. (2023) · ChemBioChem · doi:10.1002/cbic.202200801 · Cited by 24
Advances and challenges in CRISPR-based real-time imaging of dynamic genome organization
Thuma, J. L., Chung, Y.-C., & Tu, L. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1173545 · Cited by 23
“, 2022), and other areas in various biological systems [for a complete review, see (Wang et al., 2016; Knott and Doudna, 2018)].”
BackgroundRNase H-Driven crRNA Switch Circuits for Rapid and Sensitive Detection of Various Analytical Targets
Li, H., Fang, G., Ye, B., & Yin, B. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c04267 · Cited by 21
Yang, J., Matsushita, S., Xia, F., Yoshizawa, S., & Iwasaki, W. (2024) · Methods in Ecology and Evolution · doi:10.1111/2041-210x.14369 · Cited by 26
“Clustered regularly interspaced short palindromic repeat (CRISPR)- associated Cas proteins, which accurately target specific nucleic acid sequences, are widely used for genome editing (Knott & Doudna, 2018 ).”
Huang, L., Zhang, W., Liu, M., Gong, Y., Tang, Q., Wang, K., Liao, X., Zhang, K., & Wei, J. (2024) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2024.108815 · Cited by 21
Rouet, R., & Christ, D. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00116 · Cited by 24
Development of a Cas12a-Based Genome Editing Tool for Moderate Thermophiles
Mohanraju, P., Mougiakos, I., Albers, J., Mabuchi, M. Y., Fuchs, R. T., Curcuru, J. L., van Kranenburg, R., Robb, G. B., & John van der, O. O. S. T. (2021) · The CRISPR Journal · doi:10.1089/crispr.2020.0086 · Cited by 21
Kong, G., Zhang, M., Xiong, M., Chen, M., Yang, C., Zhao, Y., Yang, Y., Zhao, Z., Song, Z., Gong, L., et al. (2021) · Science China Chemistry · doi:10.1007/s11426-020-9927-9 · Cited by 21
CRISPR-Cas technology in corn: a new key to unlock genetic knowledge and create novel products
Nuccio, M. L., Claeys, H., & Heyndrickx, K. S. (2021) · Molecular Breeding · doi:10.1007/s11032-021-01200-9 · Cited by 24
Chen, S., Daly, P., Zhou, D., Li, J., Wang, X., Deng, S., Feng, H., Wang, C., Sheikh, T. M. M., Chen, Y., et al. (2022) · Fungal Biology Reviews · doi:10.1016/j.fbr.2022.03.001 · Cited by 21
Ahamed, M. A., Politza, A. J., Liu, T., Khalid, M. A. U., Zhang, H., & Guan, W. (2024) · Nanotechnology · doi:10.1088/1361-6528/ad892b · Cited by 20
Applications of CRISPR Technologies in Forestry and Molecular Wood Biotechnology
Cao, H. X., Michels, D., Vu, G. T. H., & Gailing, O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111792 · Cited by 21
“The most widely employed system for genome editing utilizes the Streptococcus pyogenes Class 2 Type II Cas9 effector [36].”
MethodShi, K., Chen, J., Cheng, Y., Song, J., Li, Y., Cheng, X., Bai, X., Chang, J., & Jiang, T. (2025) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2025.138491 · Cited by 20
Synthetic Biology of Plants and Microbes for Agriculture, Environment, and Future Applications
Clauer, P. R., Nou, A., Toth, T., Yu, Q., Chemla, Y., Boo, A., Yoon, K. S., & Voigt, C. A. (2026) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00687 · Cited by 24
Genetically encoded RNA nanodevices for cellular imaging and regulation
Yu, Q., Ren, K., & You, M. (2021) · Nanoscale · doi:10.1039/d0nr08301a · Cited by 20
Novel strategies for immuno-oncology breakthroughs with cell therapy
Liu, H., Pan, C.-X., Song, W., Liu, D., Li, Z., & Zheng, L. (2021) · Biomarker Research · doi:10.1186/s40364-021-00316-6 · Cited by 21
Wu, M., Chen, X., Xu, Q., Zang, L., Wang, S., Li, M., & Xiao, D. (2022) · Journal of Insect Science · doi:10.1093/jisesa/ieac048 · Cited by 20
Li, M., Sun, J., & Shi, G. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1220376 · Cited by 21
“Large scale gene screen tools based on the CRISPR-Cas9 system have been used to analyze gene functions and biological pathways related to human diseases (including cancer), which has become a revolution for research (Komor et al., 2017; Knott and Doudna, 2018).”
BackgroundMobile genetic element-based gene editing and genome engineering: Recent advances and applications
Hwang, J., Ye, D.-Y., Jung, G. Y., & Jang, S. (2024) · Biotechnology Advances · doi:10.1016/j.biotechadv.2024.108343 · Cited by 21
Structural basis of Cas3 activation in type I-C CRISPR-Cas system
Kim, D. Y., Lee, S. Y., Ha, H. J., & Park, H. H. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae723 · Cited by 23
Homologous Recombination: A GRAS Yeast Genome Editing Tool
Bernardi, B., & Wendland, J. (2020) · Fermentation · doi:10.3390/fermentation6020057 · Cited by 20
“, the target sequence can be engineered so that any target in any organism can be manipulated (Figure 5) [72,73].”
BackgroundDesigning custom CRISPR libraries for hypothesis-driven drug target discovery
Iyer, V. S., Jiang, L., Shen, Y., Boddul, S. V., Panda, S. K., Kasza, Z., Schmierer, B., & Wermeling, F. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.08.009 · Cited by 23
Genome-based therapeutic interventions for β-type hemoglobinopathies
Karamperis, K., Tsoumpeli, M. T., Kounelis, F., Koromina, M., Mitropoulou, C., Moutinho, C., & Patrinos, G. P. (2021) · Human Genomics · doi:10.1186/s40246-021-00329-0 · Cited by 21
“The most common and efficient genome editing systems include the zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), or clustered regularly interspaced short palindromic repeats/CRISPRassociated protein 9 (CRISPR/Cas9) [148, 168, 169].”
BackgroundWang, X., Qin, Y., Huang, Y., Hu, K., Zhao, S., & Tian, J. (2022) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2022.121476 · Cited by 20
Chang, C., Ma, G., Cheung, E. C. W., & Hutchins, A. P. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102525 · Cited by 22
Karvelis, T., Bigelyte, G., Young, J. K., Hou, Z., Žedaveinytė, R., Budre, K., Paulraj, S., Djukanovic, V., Gasior, S. L., Šilanskas, A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/654897 · Cited by 22
Yaish, O., Asif, M., & Orenstein, Y. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac157 · Cited by 19
CRISPR-Cas13a-powered electrochemical biosensors for RNA-based disease diagnostic and monitoring
Zakiyyah, S. N., Irkham, I., Sima, K. S. P., Kharismasari, C. Y., Xi, M., Gaffar, S., Özsöz, M., Paolucci, F., Valenti, G., & Hartati, Y. W. (2025) · Sensors and Actuators Reports · doi:10.1016/j.snr.2025.100358 · Cited by 23
Structural basis for anti-CRISPR repression mediated by bacterial operon proteins Aca1 and Aca2
Liu, Y., Zhang, L., Guo, M., Chen, L., Wu, B., & Huang, H. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101357 · Cited by 20
“(3) The crystals of the Aca1–IR2 complex were crystallized in 0.”
BackgroundZhang, Y., Song, Y., Weng, Z., Yang, J., Avery, L., Dieckhaus, K. D., Lai, R. Y., Gao, X., & Zhang, Y. (2023) · Lab on a Chip · doi:10.1039/d3lc00372h · Cited by 20
Genetic Engineered Ultrasound-Triggered Injectable Hydrogels for Promoting Bone Reconstruction
Zhao, Z., Ruan, H., Chen, A., Xiong, W., Zhang, M., Cai, M., & Cui, W. (2023) · Research · doi:10.34133/research.0221 · Cited by 20
Gupta, J., Abullais, S. S., Althomali, R. H., Chunata, D. M. G., Abdullaev, S. S., Yeslam, H. E., Sarsembenova, O., Ramadan, M. F., Alsalamy, A., & Alkhayyat, S. (2023) · Microchemical Journal · doi:10.1016/j.microc.2023.109268 · Cited by 21
Conformational dynamics of CasX (Cas12e) in mediating DNA cleavage revealed by single-molecule FRET
Xing, W., Li, D., Wang, W., Liu, J., & Chen, C. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae604 · Cited by 24
“Dead Cas proteins, such as dead Cas9 and dead Cas12a, can be fused with other effector proteins and repurposed for gene regulation, base editing, prime editing, and other applications due to their RNA-guided DNA-binding activities ( 26–28 ).”
Expanding the horizon of CAR T cell therapy: from cancer treatment to autoimmune diseases and beyond
Yang, Z., Ha, B., Wu, Q., Ren, F., Yin, Z., & Zhang, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1544532 · Cited by 24
“Compared with NHEJ, after double-stranded DNA is cleaved by sgRNA, homologous directed repair can deliver larger gene sequences to precise sites in the genome (157 – 159).”
Blossom of CRISPR technologies and applications in disease treatment
Liu, H., Wang, L., & Luo, Y. (2018) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2018.10.003 · Cited by 21
“After the emergence of CRISPR technology derived from the bacterial adaptive immune system, the researchers' abilities to sculpt the genome and program the gene expression have been enhanced to another level [4].”
BackgroundWu, Y., Zhou, L., Wang, Z., Wang, X., Zhang, R., Zheng, L., & Kang, T. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0162 · Cited by 19
Characterization of a Novel CYP1A2 Knockout Rat Model Constructed by CRISPR/Cas9
Sun, D., Lu, J., Zhang, Y., Liu, J., Liu, Z., Yao, B., Guo, Y., & Wang, X. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000403 · Cited by 19
“However, these technology barriers were broken during the birth of CRISPR/Cas9 technology (Knott and Doudna, 2018).”
Backgroundtrans Single‐Stranded DNA Cleavage via CRISPR/Cas14a1 Activated by Target RNA without Destruction
Wei, Y., Yang, Z., Zong, C., Wang, B., Ge, X., Tan, X., Liu, X., Tao, Z., Wang, P., Ma, C., et al. (2021) · Angewandte Chemie · doi:10.1002/ange.202110384 · Cited by 19
Chen, Y., Niu, X., Cheng, M., Wang, L., Sun, P., Song, H., & Cao, Y. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00149 · Cited by 21
Dynamic basis of supercoiling-dependent DNA interrogation by Cas12a via R-loop intermediates
Aris, K., Cofsky, J. C., Shi, H., Al-Sayyad, N., Ivanov, I. E., Balaji, A., Doudna, J. A., & Bryant, Z. D. (2025) · Nature Communications · doi:10.1038/s41467-025-57703-y · Cited by 21
Self-citationGao, F., Shi, S., Zhao, Y., Yang, D. J., & Liao, X. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108712 · Cited by 21
Precision gene editing: The power of CRISPR-Cas in modern genetics
Joo, J. H., Lee, S., & Kim, K. P. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102733 · Cited by 25
Imaging whole nervous systems: insights into behavior from worms to fish
Calarco, J. A., & Samuel, A. D. T. (2018) · Nature Methods · doi:10.1038/s41592-018-0276-8 · Cited by 19
The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System
Qiao, H., Wu, J., Zhang, X., Luo, J., Wang, H., & Ming, D. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.786354 · Cited by 22
“The CRISPR-Cas9 system consists of two components: A Cas protein with DNase properties (Cas9) and a single-stranded guide RNA (sgRNA) (Knott and Doudna, 2018; Li L. et al., 2018).”
BackgroundHigh-efficiency retron-mediated single-stranded DNA production in plants
Jiang, W., Rao, G. S., Aman, R., Butt, H., Kamel, R., Sedeek, K., & Mahfouz, M. M. (2022) · Synthetic Biology · doi:10.1093/synbio/ysac025 · Cited by 19
Genome editing technology and applications with the type I CRISPR system
Yoshimi, K., & Mashimo, T. (2022) · Gene and Genome Editing · doi:10.1016/j.ggedit.2022.100013 · Cited by 24
CRISPR/Cas9-based genome editing for multimodal synergistic cancer nanotherapy
Pu, Y., Wu, W., Xiang, H., Chen, Y., & Xu, H. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101734 · Cited by 19
CRISPR-Cas9 for sustainable food production: Impacts, recent advancements and future perspectives
Ray, S., Sneha, K., & Jangid, C. (2023) · Food and Humanity · doi:10.1016/j.foohum.2023.10.014 · Cited by 25
Song, G., Tian, C., Li, J., Zhang, F., Peng, Y., Gao, X., & Tian, Y. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad995 · Cited by 22
Metadata
- Authors
- Knott, G. J., & Doudna, J. A.
- Affiliations
- University of California, Berkeley (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Doudna, Jennifer A.
- Venue
- Science
- Published
- 2018-08-31
- Volume
- 361
- Issue
- 6405
- Pages
- 866-869
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6455913
- OpenAlex
- W2888908334
- Cited by
- 1,410
- References
- 76
- Citations by year
- 2026: 92 · 2025: 155 · 2024: 169 · 2023: 177 · 2022: 214 · 2021: 223 · 2020: 205 · 2019: 149 · 2018: 23
- FWCI
- 14.76
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR-Cas, genome editing, transcriptional regulation, CRISPR-Cas diagnostics, agricultural biotechnology
- MeSH terms
- Gene Editing, CRISPR-Associated Protein 9, RNA, Guide, CRISPR-Cas Systems, Animals, Bacterial Proteins, DNA, Endonucleases, Genetic Engineering, Humans, Plants, RNA, Transcription, Genetic, Molecular Imaging, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.